# Tecfidera Slow-Titration Study

> **NCT02428231** · PHASE3 · TERMINATED · sponsor: **Biogen** · enrollment: 62 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** dimethyl fumarate

## Key facts

- **NCT ID:** NCT02428231
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-04
- **Primary completion:** 2015-12
- **Final completion:** 2016-01
- **Target enrollment:** 62 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2017-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02428231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02428231, "Tecfidera Slow-Titration Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02428231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*